skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

69 Total results for product and free and sample content found

Pharmaprojects

Pharma R&D Annual Review 2018 Supplement

By Ian Lloyd 10 Apr 2018

You’ve already tuned into Pharma R&D Annual Review 2018, the free, music-themed whitepaper from Citeline’s Pharmaprojects. Now, get even more free market data and insights with your download of Pharma R&D Annual Review 2018 Supplement: New Active Substances Launched During 2017.

Topic Drug development landscape

Biomedtracker

2018 JP Morgan Healthcare Conference Review

05 Apr 2018

Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.

Topic Strategy

Pharmaprojects, Citeline

Pharma R&D Annual Review 2018

By Ian Lloyd 05 Apr 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Topic Research

Pharmaprojects

Microbiome Modulator Drugs – The New Generation of Therapeutic

By Hannah ​Sally 29 Mar 2018

Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the potential of microbiome modulating therapies.

Topic Microbiome

Pharmaprojects

Pharma R&D Annual Review 2017 Supplement

By Ian Lloyd 21 Mar 2018

Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2017, this supplement takes a look at the industry’s success stories of 2016 – the drugs which were launched on to the market for the first time during the year.

Citeline, Trialtrove

Rheumatoid Arthritis - Old and New Approaches Shifting the Treatment Paradigm

By Laura Runkel 21 Feb 2018

Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.

Trialtrove

Sepsis and the Receding Grail

05 Jan 2018

Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.

Trialtrove, Chinatrove

Is China the Dark Horse in Clinical Development?

By ​Heidi Chen 30 Nov 2017

Over the last decade, it is undeniable that China has emerged as a rising star in pharmaceutical R&D

Topic Clinical trials

Chinatrove, Sitetrove

Bioequivalence Trials in China and the Increased Need for Reliable CROs

By Christina DeRuzza 24 Nov 2017

China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.

Topic Clinical trials Drug review

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: